Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alkermes plc (ALKS)

« Back to company index

ALKS Chatter Timeline

Stock Ticker for ALKS

Most Active Tweeters for ALKS

UserTweets
@AmericanBanking 4
@dailypoliticaln 4
@ZolmaxNews 3
@WatchlistN 2
@EnterpriseLeade 2

Recent Tweets for ALKS

TickerReport @TickerReport
Alkermes $ALKS Receives Buy Rating from Cowen https://t.co/qT9JyyHnhj
2:09am
ZolmaxNews @ZolmaxNews
Alkermes $ALKS Upgraded at BidaskClub https://t.co/laDwauhonh
September 15th 2019, 1:09am
dailypoliticaln @dailypoliticaln
Alkermes $ALKS Upgraded at BidaskClub https://t.co/RwYykf4jpW
September 15th 2019, 1:09am
ConsumerFeed @ConsumerFeed
Alkermes’ $ALKS “Buy” Rating Reaffirmed at Cowen https://t.co/NsA3vicaDd
September 14th 2019, 3:09pm
EnterpriseLeade @EnterpriseLeade
Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/C2h8gDrjBQ
September 14th 2019, 2:09pm
registrarjourn @registrarjourn
Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/GDBrGX203P
September 14th 2019, 2:09pm
dispatchtribune @dispatchtribune
Insider Selling: Alkermes Plc $ALKS CEO Sells 100,000 Shares of Stock https://t.co/ugXE0wWSit
September 14th 2019, 2:09pm
OlympiaReport @OlympiaReport
Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/grTTZw5smX
September 14th 2019, 2:09pm
WatchlistN @WatchlistN
Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.39 EPS https://t.co/munrBxIPU5
September 14th 2019, 1:09pm
ZolmaxNews @ZolmaxNews
Alkermes Plc $ALKS Expected to Post Quarterly Sales of $250.98 Million https://t.co/wuXlixCBKP
September 14th 2019, 1:09pm
dailypoliticaln @dailypoliticaln
Alkermes Plc $ALKS Expected to Announce Earnings of -$0.39 Per Share https://t.co/qM2eXbgrku
September 14th 2019, 1:09pm
TickerReport @TickerReport
Alkermes $ALKS Raised to “Hold” at BidaskClub https://t.co/R1VkrnTKSj
September 14th 2019, 7:09am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $ALKS for you: 4.39% https://t.co/QC07r3PdnH
September 13th 2019, 9:09pm
AmericanBanking @AmericanBanking
Alkermes Plc $ALKS CEO Sells $2,268,000.00 in Stock https://t.co/rIZLw5fBr1 #stocks
September 13th 2019, 6:09pm
ZolmaxNews @ZolmaxNews
Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares https://t.co/uRJ0owK2p6
September 13th 2019, 6:09pm
dailypoliticaln @dailypoliticaln
Alkermes Plc $ALKS CEO Sells $2,268,000.00 in Stock https://t.co/cfXmH5RKvH
September 13th 2019, 6:09pm
InsiderAlertsIA @InsiderAlertsIA
$ALKS: New Insider Filing on Director and CEO, Alkermes plc RICHARD F POPS: https://t.co/R8pE0beosY
September 13th 2019, 5:09pm
Briefingcom @Briefingcom
$ALKS: Alkermes founder Floyd Bloom, M.D. retires from Board https://t.co/EvbUVYvl7m
September 13th 2019, 9:09am
Stock_News_Now @Stock_News_Now
$ALKS: New SEC Filing for ALKS: Form 8-K (No. 0001564590-19-034637): https://t.co/wNHFjab1Yp
September 13th 2019, 8:09am
AmericanBanking @AmericanBanking
Alkermes’ $ALKS “Buy” Rating Reaffirmed at Cowen https://t.co/bfF7MoIaub #stocks
September 13th 2019, 8:09am
StockTexts @StockTexts
$ALKS Alkermes plc SEC Filing: Form 8-K https://t.co/FimXrwS6T7
September 13th 2019, 7:09am
confcalltran @confcalltran
Alkermes Announces The Appointment Of Richard Gaynor, M.D. And Andy Wilson To Its Board Of Dire https://t.co/JtnTaedObI $ALKS
September 13th 2019, 7:09am
ProVesting @ProVesting
$ALKS: Alkermes Announces the Appointment of Richard Gaynor, MD and …: https://t.co/tr18yGxRYr
September 13th 2019, 7:09am
stocknewstimes @stocknewstimes
Zacks: Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.20 Earnings Per Share https://t.co/YIgjqsZKq6
September 12th 2019, 5:09pm
macondailynews @macondailynews
Zacks: Brokerages Anticipate Alkermes Plc $ALKS to Post -$0.20 Earnings Per Share https://t.co/9TZ7KYYFXM
September 12th 2019, 5:09pm
TheMarketsDaily @TheMarketsDaily
Alkermes Plc $ALKS Expected to Announce Earnings of -$0.20 Per Share https://t.co/IXGqQBjs6b
September 12th 2019, 5:09pm
AmericanBanking @AmericanBanking
$250.98 Million in Sales Expected for Alkermes Plc $ALKS This Quarter https://t.co/FVIU0NVlBI #stocks
September 11th 2019, 5:09am
dispatchtribune @dispatchtribune
Alkermes $ALKS Shares Up 6.8% https://t.co/Bop4yhK1lt
September 10th 2019, 11:09pm
OlympiaReport @OlympiaReport
Alkermes $ALKS Shares Up 6.8% https://t.co/UanOt8oZW7
September 10th 2019, 11:09pm
registrarjourn @registrarjourn
Alkermes $ALKS Shares Up 6.8% https://t.co/XnYFVcUlK8
September 10th 2019, 11:09pm
EnterpriseLeade @EnterpriseLeade
Alkermes $ALKS Shares Up 6.8% https://t.co/N7PW5veGmH
September 10th 2019, 11:09pm
SeekingAlpha @SeekingAlpha
$ALKS - Alkermes (ALKS) Investor Presentation - Slideshow https://t.co/zzc4wK1O3f
September 10th 2019, 3:09pm
AmericanBanking @AmericanBanking
Brokerages Expect Alkermes Plc $ALKS Will Announce Earnings of -$0.20 Per Share https://t.co/urADBxXnJ3 #stocks
September 9th 2019, 2:09am
WeekHerald @WeekHerald
Alkermes Plc $ALKS Receives $31.70 Average Price Target from Analysts https://t.co/zkeEeOSCvT
September 9th 2019, 12:09am
ThisLincolnian @ThisLincolnian
Alkermes Plc $ALKS Given Average Rating of “Hold” by Analysts https://t.co/rAardkt4rQ
September 9th 2019, 12:09am
stocknewstimes @stocknewstimes
Alkermes $ALKS Raised to “Equal” at Morgan Stanley https://t.co/SYe3SZmk5N
September 8th 2019, 9:09am
TranscriptDaily @TranscriptDaily
Alkermes $ALKS Raised to “Equal” at Morgan Stanley https://t.co/16PQN2jHKH
September 8th 2019, 9:09am
dailypoliticaln @dailypoliticaln
Alkermes Plc $ALKS CEO Richard F. Pops Sells 100,000 Shares of Stock https://t.co/tOAOhGHJL3
September 7th 2019, 1:09pm
WatchlistN @WatchlistN
Insider Selling: Alkermes Plc $ALKS CEO Sells 100,000 Shares of Stock https://t.co/5mLHly6Tw1
September 7th 2019, 1:09pm
1MinuteStock @1MinuteStock
Wondering about risks of $ALKS? The 63-day volatility is 22.22% https://t.co/cQn3ldIe1K
August 11th 2019, 5:08am
ZolmaxNews @ZolmaxNews
Alkermes $ALKS Shares Up 5.3% https://t.co/bCRBFC2LZC
August 10th 2019, 5:08pm
OlympiaReport @OlympiaReport
Analysts Set Alkermes Plc $ALKS Price Target at $31.70 https://t.co/gtPMsuBtuW
August 10th 2019, 5:08pm
ThisLincolnian @ThisLincolnian
Analysts Set Alkermes Plc $ALKS Price Target at $31.70 https://t.co/cYURmfqVWW
August 10th 2019, 5:08pm
WeekHerald @WeekHerald
Alkermes Plc $ALKS Receives $31.70 Consensus Price Target from Brokerages https://t.co/0jjd1Pf2oi
August 10th 2019, 5:08pm
bbnsnews @bbnsnews
Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/BL1zrZcRl1
August 8th 2019, 2:08pm
AmericanBanking @AmericanBanking
Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/2upCOZIEZt #stocks
August 8th 2019, 2:08pm
ThisLincolnian @ThisLincolnian
Weekly Research Analysts’ Ratings Updates for Alkermes $ALKS https://t.co/IDKTL63qdt
August 8th 2019, 2:08pm
AmericanBanking @AmericanBanking
Alkermes Plc $ALKS Receives Average Rating of “Hold” from Brokerages https://t.co/cgJGPjrN6T #stocks
August 7th 2019, 10:08am
ConsumerFeed @ConsumerFeed
Alkermes Plc $ALKS Receives Average Rating of “Hold” from Brokerages https://t.co/vj6hBpm9TH
August 7th 2019, 10:08am
fda_tracker @fda_tracker
$ALKS Phase 3 trial w/est Aug completion date NCT02873208: https://t.co/kfFuXWDuJ7 Trial Tracker: https://t.co/aR7q5oJwjn
August 6th 2019, 9:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.